DNA methylations of brain-derived neurotrophic factor exon VI are associated with major depressive disorder and antidepressant-induced remission in females
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 295, 101-107
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81971277)
- Jiangsu Provincial Key Research and Development Program (BE2019748)
This publication has 65 references indexed in Scilit:
- Interaction between stress and the BDNFVal66Met polymorphism in depression: a systematic review and meta-analysisBMC Medicine, 2014
- DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEPTranslational Psychiatry, 2013
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disordersThe World Journal of Biological Psychiatry, 2013
- Phosphorylation of MeCP2 at Ser421 Contributes to Chronic Antidepressant ActionJournal of Neuroscience, 2012
- DNA Methylation Profiles of the Brain-Derived Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic Biomarker in Major DepressionPLOS ONE, 2011
- DNA methylation status predicts cell type‐specific enhancer activityThe EMBO Journal, 2011
- Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoterExperimental Cell Research, 2009
- Gender-Specific Impact of Brain-Derived Neurotrophic Factor Signaling on Stress-Induced Depression-Like BehaviorBiological Psychiatry, 2009
- Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promotersGenomics, 2007
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987